Page last updated: 2024-11-04

sumatriptan and Clerambault Syndrome

sumatriptan has been researched along with Clerambault Syndrome in 1 studies

Sumatriptan: A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of MIGRAINE DISORDERS.
sumatriptan : A sulfonamide that consists of N,N-dimethyltryptamine bearing an additional (N-methylsulfamoyl)methyl substituent at position 5. Selective agonist for a vascular 5-HT1 receptor subtype (probably a member of the 5-HT1D family). Used (in the form of its succinate salt) for the acute treatment of migraine with or without aura in adults.

Research Excerpts

ExcerptRelevanceReference
"The question whether symptom-free migraine patients show cognitive impairments compared to matched control subjects is addressed, and also whether migraine patients show transient cognitive impairments induced by an attack."1.30Interictal and postictal cognitive changes in migraine. ( de Geus, EJ; Linssen, WH; Mulder, EJ; Orlebeke, JF; Passchier, J, 1999)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mulder, EJ1
Linssen, WH1
Passchier, J1
Orlebeke, JF1
de Geus, EJ1

Other Studies

1 other study available for sumatriptan and Clerambault Syndrome

ArticleYear
Interictal and postictal cognitive changes in migraine.
    Cephalalgia : an international journal of headache, 1999, Volume: 19, Issue:6

    Topics: Adult; Attention; Cognition Disorders; Female; Humans; Male; Migraine Disorders; Neurocognitive Diso

1999